As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at ...
Johnson & Johnson is taking flight with the New York Jets, joining the NFL team’s roster in a multiyear agreement as its ...
In sum, Novartis accused Alexion of launching “a false and misleading marketing campaign that is unsupported by scientific ...
Moderna is backing the American Lung Association’s (ALA’s) call for people with lung diseases to get vaccinated for the ...
With plans to pay up to $2.1 billion to acquire its Dublin, Ireland, neighbor Avadel Pharmaceuticals, Alkermes is hoping to ...
Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...
The FDA’s recent barrage of letters calling out alleged violatio | The FDA’s recent barrage of letters calling out alleged ...
Trump admin readies 'imminent' probe into other nations' drug pricing, raising new tariff threat: FT
Just as pharmaceutical tariff uncertainty seemed to be easing in the U.S., the Trump administration is reportedly staging a ...
Regeneron has settled its patent dispute with Celltrion, giving the go-ahead for another biosimilar to its blockbuster eye drug Eylea (aflibercept) to hit the U.S. market in just over a year. | With ...
The understated green and white box labeled Aspirina that started rolling out in select Walmart and Walgreens locations this ...
Kristen Raimondi, who has now been with Regeneron for over five years and working on its hematology marketing since 2023, ...
Axial Therapeutics has stepped back into the spotlight, emerging after almost two years of silence with a new name, focus and financing. | Axial Therapeutics has stepped back into the spotlight, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback